The BTNX Rapid Response™ COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal secretion samples.

The Rapid Response™ antigen test device is the perfect screening tool for organizations that want to protect their workplace from the risk of COVID-19 lockdowns.  

Used as part of a comprehensive rapid testing program for COVID-19, the BTNX nasal device offers fast, easy-to-use, and reliable screening. Testing all staff 1-2 times/week help detect the virus early and decrease the likelihood of spreading COVID-19.

  • Time to results: 15 minutes
  • Specimen: nasal swabs
  • Format: cassette
  • Storage conditions: 2-30°C/36-86°F

The Rapid Response™ test device is manufactured in Canada by BTNX Inc. and was authorized for use by Health Canada on February 19, 2021. 

Buy the BTNX Rapid Response™ COVID-19 Antigen Rapid Test Device for Your Workplace

If your company or organization is interested in rapid testing solutions, contact us today for help procuring the BTNW Rapid Response™ test device or other rapid tests approved by Health Canada. Our team at Rapid Test & Trace Canada can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Proudly trusted by hundreds of organizations across Canada

Stay up to date with Rapid Test & Trace Canada

Scroll to Top